Emergy Phaarma
In the Dec 2025 quarter, revenue rose 15.3% year on year to ₹141.21 Cr and net profit was −₹7.12 Cr, against −₹0.96 Cr a year earlier (compared with Dec 2024). Promoters held 68.90% of Emergy Phaarma in Dec 2025, unchanged from Sep 2025.
Peer Comparison
Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
| ₹1,768.00 | 35.07 | 4,24,202 Cr | 5.08 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,657.50 | 87.65 | 2,56,376 Cr | 15.30 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,609.50 | 72.36 | 1,75,331 Cr | 9.54 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,187.70 | 108.09 | 1,18,204 Cr | 22.30 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.60 | 26.29 | 1,17,865 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,339.00 | 34.68 | 1,11,764 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,365.50 | 32.71 | 1,10,313 Cr | 3.12 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
Emergy Phaarma (this company) | — | — | — | — | — | — | — | 550 Cr | -14 Cr |
| Median 8 companies | ₹1,768.00 | 35.07 | 1,18,204 Cr | 5.08 | 0.61% | 13.79% | 17.94% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
change over 1 year
Quarterly Results
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 91.09 | 41.16 | 91.67 | 143 | 115 | 45.64 | 97.92 | 168 | 122 | 68.44 | 115 | 171 | 141 |
| Expenses | 87.61 | 83.64 | 98.02 | 143 | 153 | 150 | 91.28 | 121 | 136 | 129 | 90.92 | 141 | 143 |
| Operating Profit | 3.48 | -42.48 | -6.35 | -0.24 | -37.58 | -104 | 6.64 | 46.67 | -13.46 | -60.83 | 24.06 | 29.61 | -1.67 |
| OPM % | 3.82% | -103.21% | -6.93% | -0.17% | -32.58% | -228.53% | 6.78% | 27.85% | -10.99% | -88.88% | 20.93% | 17.32% | -1.18% |
| Other Income | 3.47 | 1.07 | 4.54 | 8.07 | 0.91 | 7.82 | 0.75 | 0.79 | 16.52 | 15.04 | 1.53 | 2.53 | 2.71 |
| Interest | 1.97 | 2.74 | 3.43 | 6.03 | 3.05 | 4.57 | 5.08 | 6.19 | 5.65 | 5.68 | 4.32 | 5.82 | 3.87 |
| Depreciation | 4.72 | 4.36 | 6.03 | 5.92 | 5.42 | 4.54 | 5.23 | 4.89 | 4.54 | 4.24 | 5.25 | 5.23 | 4.63 |
| PBT | 0.26 | -48.51 | -11.27 | -4.12 | -45.14 | -106 | -2.92 | 36.38 | -7.13 | -55.71 | 16.02 | 21.09 | -7.46 |
| Tax % | -3553.85% | -11.94% | -15.88% | -6.8% | -1.82% | -20.96% | 1.03% | 28.53% | -86.54% | -24.39% | 10.36% | -0.28% | -4.56% |
| Net Profit | 9.5 | -42.72 | -9.48 | -3.84 | -44.32 | -83.47 | -2.95 | 25.99 | -0.96 | -42.12 | 14.35 | 21.16 | -7.12 |
| EPS (₹) | 9.04 | -40.66 | -9.02 | -3.65 | -42.18 | -79.44 | -2.81 | 24.73 | -0.91 | -40.09 | 13.66 | 20.14 | -6.78 |
Profit & Loss
| Particulars | Sep 2006 | Sep 2007 |
|---|---|---|
| Sales | 0 | 0 |
| Expenses | 0.09 | 0.03 |
| Operating Profit | -0.09 | -0.03 |
| Other Income | 0.28 | 0 |
| Interest | 0 | 0 |
| Depreciation | 0.24 | 0.21 |
| PBT | -0.05 | -0.24 |
| Tax % | 0% | 0% |
| Net Profit | -0.05 | -0.24 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Sep 2006 | Sep 2007 |
|---|---|---|
| Equity Capital | 4.75 | 4.75 |
| Reserves | -11.86 | -12.1 |
| Borrowings | 8.39 | 8.42 |
| Other Liabilities | 0.78 | 0.78 |
| Total Liabilities | 2.06 | 1.85 |
| Fixed Assets | 2.04 | 1.83 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 0.02 | 0.02 |
| Total Assets | 2.06 | 1.85 |
Cash Flow
| Particulars | Sep 2006 | Sep 2007 |
|---|---|---|
| Operating | -0.03 | -0.03 |
| Investing | 0 | 0 |
| Financing | 0.03 | 0.03 |
| Net Cash Flow | 0 | 0 |
| Free Cash Flow | -0.03 | -0.03 |
| CFO/OP | 33 | 100 |
Ratios
| Particulars | Sep 2006 | Sep 2007 |
|---|---|---|
| ROCE % | — | -20.43% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Emergy Phaarma insights
11 extracted metrics + investor summaries across FY23–FY26.
Documents
Frequently Asked Questions about Emergy Phaarma
Where is Emergy Phaarma Ltd (524812) listed?
Which sector does Emergy Phaarma Ltd belong to?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524812.md for Emergy Phaarma Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.